Abstract
Pretreatment and preoperative assessment of peritoneal carcinomatosis (PC) can be very challenging in the field of imaging, and a comprehensive study could require integration of multidetector computed tomography (MDCT), magnetic resonance imaging (MRI) with conventional and diffusion-weighted sequences, and positron emission tomography (PET) or PET/CT [1, 2]. These imaging tools are able to provide accurate information on morphology, size, and location of peritoneal implants, lymph node enlargement, and presence of ascites. A detailed preoperative assessment of PC is essential to provide the surgeon with a detailed preoperative map of carcinomatosis and allow evaluation of the radiological Peritoneal Cancer Index (PCI) [3, 4]. This score correlates with patient prognosis, and the ability to calculate it using CT and MR with diffusion-weighted imaging (DWI) before any treatment is begun can guide therapeutic management of the patient. It can differentiate patients who are candidates for surgical intervention with hyperthermic intraperitoneal chemotherapy (HIPEC) from those with a high radiological PCI and who are therefore candidates for systemic chemotherapy [5]. The principal diagnostic techniques for accurate evaluation of peritoneal malignancy are represented by MDCT, MRI, PET, and combined PET/MDCT or PET/MRI. The role of ultrasound (US) imaging is limited in peritoneal imaging. However, this imaging modality is often the first one used when peritoneal disease is discovered incidentally, and it remains one of the diagnostic techniques for image-guided biopsy to obtain a histological diagnosis [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Patel CM, Sahdev A, Reznek RH (2011) CT, MRI and PET imaging in peritoneal malignancy Cancer Imaging 11:123–139
Iafrate F, Ciolina M, Laghi A et al (2012) Peritoneal carcinomatosis: imaging with 64-MD-CT and 3T MRI with diffusion-weighted imaging. Abdom Imaging 37:616–627
Koh JL, Yan TD, Glenn D, Morris DL (2009) Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol 16:327–333
Verwaal VJ, Bruin S, Boot H et al (2008) 8-Year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 15:2633–2635
Esquivel J, Sticca R, Sugarbaker P et al (2007) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol 14:128–133
Kim SJ, Kim HH, Kim YH et al (2009) Peritoneal metastasis: detection with 16- or 64-detector row CT in patients undergoing surgery for gastric cancer. Radiology 253:407–415
Marin D, Catalano C, Baski M et al (2010) 64-Section multi- detector row CT in the preoperative diagnosis of peritoneal carci- nomatosis: correlation with histopathological findings. Abdom Imaging 35:694–700
Pannu HK, Bristow r, Montz F, Fishman EK (2003) Multidetector CT of peritoneal cersinomatosis from ovarian cancer. Radiographics 23:687–701
Jacquet P, Jelinek JS, Steves MA, Sugarbaker PH (1993) Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 72:1631–1636
Amendola MA (1985) The role of CT in the evaluation of ovarian malignancy. CRC Crit Rev Diagn Imaging 24:329–368
Coakley FV, Hricak H (1999) Imaging of peritoneal and mesenteric disease: key concepts for the clinical radiologist. Clin Radiol 54:563–574
Bristow RE, Duska LR, Lambrou NC et al (2000) A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer 89:1532–1540
Jang YJ, Kim JK, Park SB, Cho KS (2007) Variable CT findings of epithelial origin ovarian carcinoma according to the degree of histologic differentiation. Korean J Radiol 8:120–126
Tempany CM, Zou KH, Silverman SG et al (2000) Staging of advanced ovarian cancer: comparison of imaging modalities—report from the Radiological Diagnostic Oncology Group. Radiology 215:761–767
De Bree E, Koops W, Kröger R et al (2004) Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of pre-operative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol 86:64–73
Coakley FV, Choi P, Poturi B et al (2002) Peritoneal metastases detection with spiral CT in patient with ovarian cancer. Radiology 223:495–499
Patel CM, Sahdev A, Reznek RH (2011) CT, MRI and PET imaging in peritoneal malignancy. Cancer Imaging 11:123–139
Woodward PJ, Hosseinzadeh K, Saenger JS (2004) From the archives of the AFIP: radio- logic staging of ovarian carcinoma with pathologic correlation. RadioGraphics 24:225–246
Low RN, Barone RM, Lacey C et al (1997) Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT. Radiology 204:513–520
Fujii S, Matsusue E, Kanasaki Y et al (2008) Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging. Eur Radiol 18:18–23
Low RNI, Barone RM (2012) Combined diffusion-weighted and gadolinium-enhanced MRI can accurately predict the peritoneal cancer index preoperatively in patients being considered for cytoreductive surgical procedures. Ann Surg Oncol 19:1394–1401
Low RN (2007) MR imaging of the peritoneal spread of malignancy. Abdom Imaging 32:26783
Kyriazi S, Collins DJ, Morgan VA et al (2010) Diffusion-weighted imaging of peritoneal disease for noninvasive staging of advanced ovarian cancer. Radiographics 30:1269–1285
Low RN (2007) MR imaging of the peritoneal spread of malignancy. Abdom Imaging 32:267–283
Low RN, Sebrechts CP, Barone RM, Muller W (2009) Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings—a feasibility study. AJR Am J Roentgenol 193:461–470
Koh DM, Collins DJ (2007) Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 188:1622–1635
Kitajima K, Murakami K et al (2011) Present and future of FDG-PET/CT in ovarian cancer. Ann Nucl Med 25:155–164
Fanti S, Nanni C et al (2006) Supra-clavicular lymph node metastatic spread in patients with ovarian cancer disclosed a 18F-FDG-PET/CT: an unusual finding. Cancer Imaging 23:20–23
Nishiyama Y, Yamamoto Y et al (2008) Monitoring the neoadjuvant therapy response in gynecological cancer patients using FDG PET. Eur J Nucl Med Mol Imaging 35:287–295
Yuan Y, Gu ZX et al (2012) Computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymphnodes in patients with ovarian cancer: a meta-analysis. Eur J Radiol 81:1002–1006
Esquivel J, Sticca R, Sugarbaker P, Levine E, Yan TD, Alexander R, Baratti D, Bartlett D, Barone R, Barrios P, Bieligk S, Bretcha-Boix P, Chang CK, Chu F, Chu Q, Daniel S, de Bree E, Deraco M, Dominguez-Parra L, Elias D, Flynn R, Foster J, Garofalo A, Gilly FN, Glehen O, Gomez-Portilla A, Gonzalez-Bayon L, Gonzalez-Moreno S, Goodman M, Gushchin V, Hanna N, Hartmann J, Harrison L, Hoefer R, Kane J, Kecmanovic D, Kelley S, Kuhn J, Lamont J, Lange J, Li B, Loggie B, Mahteme H, Mann G, Martin R, Misih RA, Moran B, Morris D, Onate-Ocana L, Petrelli N, Philippe G, Pingpank J, Pitroff A, Piso P, Quinones M, Riley L, Rutstein L, Saha S, Alrawi S, Sardi A, Schneebaum S, Shen P, Shibata D, Spellman J, Stojadinovic A, Stewart J, Torres-Melero J, Tuttle T, Verwaal V, Villar J, Wilkinson N, Younan R, Zeh H, Zoetmulder F, Sebbag G; Society of Surgical Oncology Annual Meeting (2007) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Ann Surg Oncol 14:128–133
Nougaret S, Addley HC, Colombo PE et al (2012) Ovarian carcinomatosis: how the radiologist can help plan the surgical approach. Radiographics 32:1775–800
Sugarbaker PH, Ronnett BM, Archer A et al (1997) Pseudomyxoma peritonei syndrome. Adv Surg 30:233–80
Sugarbaker PH (1999) Results of treatment of 385 patients with peri- toneal surface spread of appendiceal malignancy. Ann Surg Oncol 6:727–31
Vaira M, Cioppa T, D’Amico S et al (2010) Peritoneal colorectal car- cinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 28:63–68
Glehen O, Kwiatkowski F, Sugarbaker PH et al (2005) Cytoreductive surgery combined with perioperative intraperitoneal chemother- apy for the management of peritoneal carcinomatosis from colo- rectal cancer: a multi-institutional study. J Clin Oncol 22:3284–3292
Klumpp BDI, Schwenzer N, Aschoff P et al (2013) Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI. Abdom Imaging 38:64–71
Chang MC, Chen JH, Liang JA et al (2013) PET or PET/CT for detection of peritoneal carcinomatosis: a meta-analysis. Clin Nucl Med 38:623–629
Glehen O, Kwiatkowski F, Sugarbaker PH et al (2004) Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22:3284–3292
Yan TD, Sim J, Morris DL (2007) Selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and perioperative intraperitoneal chemotherapy. Ann Surg Oncol 14:1807–1817
Bakrin N, Bereder JM, Decullier E et al (2013) Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients. Eur J Surg Oncol 39:1435–1443
Glehen O, Gilly FN, Boutitie F et al (2010) Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer 116:5608–5618
Yan TD, Morris DL, Shigeki K et al (2008). Preoperative investigations in the management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy: Expert consensus statement. J Surg Oncol 98:224–227
Rutten MJ, Leeflang MM, Kenter GG et al (2014) Laparoscopy for diagnosing resectability of disease in patients with advanced ovarian cancer. Cochrane Database Syst Rev 21;2:CD009786
Pomel C, Appleyard TL, Gouy S et al (2005). The role of laparoscopy to evaluate candidates for complete cytoreduction of peritoneal carcinomatosis and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 31:540–543
Garofalo A, Valle M (2009) Laparoscopy in the management of peritoneal carcinomatosis. Cancer J 15:190–195
Laterza B, Kusamura S, Baratti D et al (2009) Role of explorative laparoscopy to evaluate optimal candidates for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal mesothelioma. In Vivo 23:187–190
Fagotti A, Ferrandina G, Fanfani F et al (2006) A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study. Ann Surg Oncol 13:1156–1161
Fagotti A, Ferrandina G, Fanfani F et al (2008) Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma. Am J Obstet Gynecol 199:642.e1–6
Zivanovic O, Sonoda Y, Diaz JP et al (2008) The rate of port-site metastases after 2251 laparoscopic procedures in women with underlying malignant disease. Gynecol Oncol 111:431–437
Wang PH, Yuan CC, Lin G et al (1999) Risk factors contributing to early occurrence of port site metastases of laparoscopic surgery for malignancy. Gynecol Oncol 72:38–44
van Dam PA, DeCloedt J, Tjalma WA et al (1999) Trocar implantation metastasis after laparoscopy in patients with advanced ovarian cancer: can the risk be reduced? Am J Obstet Gynecol 181:536–541
Nagarsheth NP, Rahaman J, Cohen CJ et al (2004) The incidence of port-site metastases in gynecologic cancers. JSLS 8:133–139
Iversen LH, Rasmussen PC, Laurberg S (2013) Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. Br J Surg 100:285–292
Sugarbaker PH (Editor), van der Speeten K, Stuart OA et al (2012) Cytoreductive Surgery & Perioperative Chemotherapy for Peritoneal Surface Malignancy. Textbook and Video Atlas. Cine-Med Publishing: Woodbury, CT, pp. 84–85
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Italia
About this chapter
Cite this chapter
Iafrate, F., Ciolina, M., Cavallini, C., Biacchi, D., Naticchioni, E., Laghi, A. (2015). Diagnostic Imaging and Laparoscopy. In: Di Giorgio, A., Pinto, E. (eds) Treatment of Peritoneal Surface Malignancies. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-5711-1_6
Download citation
DOI: https://doi.org/10.1007/978-88-470-5711-1_6
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5710-4
Online ISBN: 978-88-470-5711-1
eBook Packages: MedicineMedicine (R0)